Legal & General Group’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$497M Sell
5,416,333
-300,641
-5% -$26.3M 0.1% 171
2026
Q1
$487M Sell
5,716,974
-29,923
-0.5% -$2.67M 0.11% 177
2025
Q4
$454M Sell
5,746,897
-172,627
-3% -$13.5M 0.1% 185
2025
Q3
$473M Buy
5,919,524
+162,253
+3% +$13.8M 0.11% 183
2025
Q2
$523M Sell
5,757,271
-252,642
-4% -$23.1M 0.13% 150
2025
Q1
$563M Buy
6,009,913
+57,341
+1% +$5.13M 0.15% 126
2024
Q4
$541M Sell
5,952,572
-73,860
-1% -$7.05M 0.14% 128
2024
Q3
$626M Sell
6,026,432
-259,886
-4% -$26.5M 0.16% 116
2024
Q2
$610M Sell
6,286,318
-282,773
-4% -$26.1M 0.17% 114
2024
Q1
$592M Sell
6,569,091
-7,964
-0.1% -$675K 0.17% 119
2023
Q4
$524M Sell
6,577,055
-53,844
-0.8% -$4.05M 0.16% 124
2023
Q3
$472M Sell
6,630,899
-184,580
-3% -$13.8M 0.16% 125
2023
Q2
$525M Buy
6,815,479
+58,128
+0.9% +$4.5M 0.17% 117
2023
Q1
$508M Sell
6,757,351
-81,530
-1% -$6.06M 0.18% 116
2022
Q4
$539M Sell
6,838,881
-333,333
-5% -$25M 0.21% 105
2022
Q3
$504M Sell
7,172,214
-537,492
-7% -$42.1M 0.2% 106
2022
Q2
$618M Buy
7,709,706
+301,219
+4% +$23.6M 0.22% 95
2022
Q1
$562M Buy
7,408,487
+444,539
+6% +$35.2M 0.17% 116
2021
Q4
$594M Sell
6,963,948
-116,556
-2% -$9.1M 0.18% 112
2021
Q3
$535M Buy
7,080,504
+374,901
+6% +$29.8M 0.17% 114
2021
Q2
$545M Buy
6,705,603
+233,643
+4% +$19.1M 0.18% 110
2021
Q1
$510M Buy
6,471,960
+62,298
+1% +$4.88M 0.19% 106
2020
Q4
$548M Buy
6,409,662
+180,435
+3% +$14.9M 0.21% 90
2020
Q3
$481M Buy
6,229,227
+73,203
+1% +$5.58M 0.21% 91
2020
Q2
$451M Buy
6,156,024
+134,203
+2% +$9.53M 0.22% 87
2020
Q1
$400M Buy
6,021,821
+54,510
+0.9% +$3.84M 0.23% 86
2019
Q4
$411M Buy
5,967,311
+71,547
+1% +$4.88M 0.2% 111
2019
Q3
$433M Buy
5,895,764
+189,802
+3% +$13.8M 0.23% 91
2019
Q2
$409M Buy
5,705,962
+156,854
+3% +$11.1M 0.22% 97
2019
Q1
$380M Buy
5,549,108
+900,796
+19% +$58.2M 0.22% 102
2018
Q4
$277M Buy
4,648,312
+333,944
+8% +$20.9M 0.21% 104
2018
Q3
$289M Buy
4,314,368
+190,876
+5% +$12.7M 0.21% 108
2018
Q2
$267M Sell
4,123,492
-140,133
-3% -$9.17M 0.21% 108
2018
Q1
$306M Sell
4,263,625
-187,499
-4% -$13.5M 0.23% 90
2017
Q4
$336M Sell
4,451,124
-95,076
-2% -$6.94M 0.24% 93
2017
Q3
$331M Buy
4,546,200
+155,883
+4% +$11.2M 0.25% 93
2017
Q2
$325M Buy
4,390,317
+96,427
+2% +$7.16M 0.26% 83
2017
Q1
$314M Buy
4,293,890
+208,905
+5% +$14.6M 0.27% 83
2016
Q4
$267M Sell
4,084,985
-102,077
-2% -$7M 0.25% 87
2016
Q3
$310M Sell
4,187,062
-7,119
-0.2% -$526K 0.31% 68
2016
Q2
$307M Buy
4,194,181
+240,916
+6% +$17.2M 0.32% 66
2016
Q1
$279M Buy
3,953,265
+50,393
+1% +$3.35M 0.31% 69
2015
Q4
$260M Buy
3,902,872
+42,863
+1% +$2.85M 0.29% 72
2015
Q3
$245M Buy
3,860,009
+114,523
+3% +$7.48M 0.3% 73
2015
Q2
$245M Buy
3,745,486
+102,614
+3% +$6.96M 0.29% 78
2015
Q1
$253M Sell
3,642,872
-66,503
-2% -$4.6M 0.3% 76
2014
Q4
$257M Sell
3,709,375
-132,634
-3% -$8.96M 0.3% 74
2014
Q3
$251M Sell
3,842,009
-20,819
-0.5% -$1.37M 0.3% 74
2014
Q2
$263M Sell
3,862,828
-74,942
-2% -$5.02M 0.31% 74
2014
Q1
$255M Sell
3,937,770
-95,898
-2% -$6.04M 0.31% 75
2013
Q4
$263M Sell
4,033,668
-40,556
-1% -$2.6M 0.32% 73
2013
Q3
$242M Sell
4,074,224
-61,371
-1% -$3.64M 0.32% 70
2013
Q2
$237M Buy
+4,135,595
New +$245M 0.33% 67

Other funds holding CL

Legal & General Group's CL Position: Q2 2026 in Review

Legal & General Group reduced its Colgate-Palmolive (CL) stake by 5.3% in Q2 2026, selling an estimated $26.3M and leaving 5,416,333 shares worth $497M. The position accounts for 0.1% of the portfolio, ranked #171.

Legal & General Group first reported a position in CL in Q2 2013 and has held it in 53 quarters since. The position peaked at $626M in Q3 2024. 2,011 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Legal & General Group held 5,416,333 shares of Colgate-Palmolive worth $497M as of Q2 2026.
  • Legal & General Group sold 300,641 Colgate-Palmolive shares in Q2 2026, an estimated $26.3M.
  • Colgate-Palmolive made up 0.1% of Legal & General Group's portfolio in Q2 2026, its #171 holding.
  • Legal & General Group first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 53 quarters since.
  • Legal & General Group's Colgate-Palmolive position peaked at $626M in Q3 2024.
  • 2,011 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.